Treatment for End Stage Interstitial Lung Disease
What is End Stage Interstitial Lung Disease?
Interstitial Lung Disease (ILD) is a canopy term used to identify a family of roughly 100 different types of pulmonary disorders that affect the absorption of oxygen in the lungs. End stage, also known as stage four ILD, is a clinical term used to describe the severity of a patient’s condition. All of these disorders alter the interstitium, which is the tissue and space surrounding the alveoli—the cluster-like air sacs—of the lungs. Typically the interstitium is not visible, but when an individual has interstitial lung disease, the interstitium becomes visible as a result of progressive scarring. This progressive scarring is characteristic of the whole family of disorders encompassed by interstitial lung disease such as pulmonary fibrosis. The scar tissue impedes the ability for oxygen to pass into the bloodstream from the lungs. Previously the effects of interstitial lung disease were completely irreversible; now there are a variety of treatments available for individuals suffering from end stage interstitial lung disease.
End Stage Interstitial Lung Disease Treatment
Unfortunately, end stage interstitial lung disease is not curable, but that does not mean that the disease is untreatable. In fact, there are many potential treatments for end stage interstitial lung disease as there are a variety of possible causes and prognoses. As an incurable disease, the treatment is not meant to make the disease disappear, but rather treatment can be used to improve a patient’s quality of life, to improve symptoms or to delay the progression of the disease. Initially, many physicians prescribe a combination of medicines to suppress the immune system, but these have not proved successful in the long run. In these situations, patients often progress further than stage four. In order to help individuals struggling to breathe, supplemental oxygen can work to prevent shortness of breath and make life more comfortable. Occasionally, pulmonary rehabilitation and nutritional counseling are offered as a means of boosting a patient’s endurance. In the most severe cases, physicians may recommend a lung transplant, but this often has limited availability and extensive requirements for procedure eligibility. Thankfully, a new treatment using cells is available as a result of the hard work of a visionary group of physicians dedicated to improving the lives of individuals with lung disease.
What is the Role of Cells?
Cells are the building blocks of every living organism. They have the ability for self-renewal and replication, thus are capable of forming any type of tissue or organ in the body. Adult cells from one organ are capable of forming tissue for another organ, which is called plasticity. It has been found that adult cells are capable of being transferred into any one single organ of the body.
Cellular Treatment for End Stage Interstitial Lung Disease
In the case of end stage interstitial lung disease,
autologous cells are used, meaning the cells come from the patient’s own body. They can be found in the patient’s bone marrow and blood (venous tissue). Cells derived from venous tissue have the capability to form many types of differentiated cells. During the procedure, adult cells are extracted from bone marrow or blood, which requires special laboratory techniques.
After extraction, the cells are isolated. Finally, they are returned to the patient intravenously. The treatment is minimally invasive and typically an outpatient procedure. The procedure should be performed in a clinical setting under the supervision of a professional. It takes a physician that has sought specific training to perform cellular therapy adequately and safely. If you would like to find out more about our available treatment options, please contact one of our patient care coordinators today at 888-745-6697 to schedule a free consultation.